Posted on July 14, 2012
Deadline: August 1, 2012 (Letters of Intent)

Alzheimer's Drug Discovery Foundation Announces Challenge Grant for Development of Biomarkers

Progress in developing effective Alzheimer's disease and dementia therapeutics has been hampered by a lack of sensitive short-term biomarkers that correlate closely to clinical outcomes. The Alzheimer's Drug Discovery Foundation is partnering with the New York Academy of Sciences to issue a challenge grant for the development and validation of such biomarkers.

Higher priority will be given to applications that involve cross-sector or interdisciplinary collaborations and innovative ideas.

Priority areas for this request for proposals include non-amyloid biomarkers of early-disease progression, detection of synaptic and/or neuronal loss, and dynamic biomarkers with sensitivity to detect change in as little as a few weeks.

Funding of $140,000 is available for a one-year project, with the possibility of follow-on funding.

Applications may be submitted by nonprofit academic institutions worldwide.

Submission of a Letter of Intent is required prior to August 1, 2012. The deadline for applications is August 15, 2012.

For complete information about the program and the online LOI submission process, visit the Alzheimer's Drug Discovery Foundation Web site.

Contact:
Link to Complete RFP

Primary Subject: Aging
Geographic Funding Area: National

Looking for additional funders in the field of Aging?
Foundation Directory Online allows you to search the entire universe of U.S. grantmakers. Target your search by field of interest, type of support, geographic focus, and more. Find the plan that's right for you»